House Rx Partners with National Cancer Care Alliance to Provide Oncology Care Teams with New Insights to Improve Specialty Medication Dispensing

House Rx Co-Founder Tesh Khullar writes about the difficulties of procuring specialty medications for anyone suffering from a debilitating or life-threatening disease. He shares insights into the bureaucracy and process around accessing specialty medications and highlights a better alternative: medically integrated dispensing (MID), where patients receive medications directly from their prescribing doctor.

Patients of Oregon Oncology Specialists will now receive dedicated support to access and manage their treatments from House Rx's team, who will work integrated with clinic staff. This approach, known as medically integrated dispensing, improves patient health outcomes by getting them started on therapy faster and providing one-on-one support around side effects and refills.

As one of CB Insights’ top 150 most promising digital health companies in the world, House Rx combines services and technology to empower clinics all over the U.S. to provide their patients with faster and more affordable access to medications.